What is LOPJLB’s current signal on RPRX?

LOPJLB’s latest quantitative signal on Royalty Pharma plc (RPRX) is SELL in a BEAR regime. Signals are updated daily.

What market regime is RPRX in?

Royalty Pharma plc (RPRX) is currently classified in the BEAR HMM market regime on LOPJLB.

Where is Royalty Pharma plc based / listed?

Royalty Pharma plc is based in US, listed on NASDAQ.

Royalty Pharma plc (RPRX)

COMPARE

Healthcare · Medical - Pharmaceuticals · NASDAQ · US

$56.93+1.28%Close

SELLBEAR · day 22

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $24.5B
Beta: 0.43
Div yield: 1.64%
P/E (TTM): 23.42

Short % float: 3.12%
Days to cover: 4.4
SI change: +10.6%

1W: -0.40%
1M: -3.10%

vs SPY 1W: -1.56%
vs SPY 1M: -6.09%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that…

Employees: 100
Headquarters: US
Founded: 2020
Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Shares out: 430.1M
Float: 96.1%

royaltypharma.com ↗

Key executives

Pablo Legorreta — Founder, Chairman of the Board & Chief Executive Officer

James Folmar Reddoch — Executive Vice President of Investments & Chief Scientific Officer

Arthur Richard McGivern — Executive Vice President of Investments & Chief Scientific Officer

SEC filings

EDGAR · CIK 18027680 · RPRX

Analyst consensus

Buy

Bullish11100.0%

Neutral00.0%

Bearish00.0%

L $57.00Avg $63.33H $67.00

Target$63.33+11.24%

Last$56.93

Key stats

Industry peers

Prediction markets

Company news